Amaero Ltd · ASX:3DA
Amaero — Shareholder Meeting (October 2024)
9 slides from Amaero's shareholder meeting presentation, Oct 29, 2024
Slide 1: A Look Back…A Look Ahead
For personal use only A Look Back…A Look Ahead Annual General Meeting | October 29, 2024
Slide 2: Important notice and disclaimer
Important notice and disclaimer This presentation has been prepared by Amaero International Ltd (ACN 633 541 634) (“Amaero” or the “Company”) and does not constitute or form part of, and should not be construed as, an offer, solicitation or invitation to subscribe for, underwrite or otherwise acquir
Slide 3: Generational Opportunity
Generational Opportunity For personal use only U.S. national policy imperative to re-shore more resilient, more scalable and more responsive industrial production and sustainment capabilities Amidst a backdrop of increasingly hostile and volatile geopolitical tensions 1
Slide 4: Amaero's Vision
Amaero’s Vision For personal use only Amaero aspires to address critical gaps in the U.S. domestic industrial production and supply chain for advanced materials and manufacturing 2
Slide 5: Three Pillars of Amaero's Business
Three Pillars of Amaero’s Business Specialty Metal Powders Production of refractory, specialty and titanium powders for the defense, aerospace For personal use only and industrial manufacturing sectors AMAERO PM HIP Near Net Shape Parts Leveraging the Amaero team’s decades of PM HIP manufacturing Sp
Slide 6: Amaero Addresses Critical Gap in the Supply Chain
Amaero Addresses Critical Gap in the Supply Chain Raw Material C103 Powder Tier 1 Supplier End Customer Provider Provider For personal use only Additive Manufacturing AM PM HIP Manufacturing Mining Melt Cast / Refractory & Defense Prime Military Feedstock Specialty Powder Contractors Branches Produc
Slide 7: A Look Back: Milestones Q1 FY2024 – Present
A Look Back Milestones Q1 FY2024 – Present For personal use only A$0.35 Offtake and preferred supplier Quarterly Activities Report Fairmont Consulting agreement and A$20M highlights transition to Prioritizes production of C103 completes comprehensive institutional capital raise commercialization and
Slide 8: A Look Ahead at FY 2025 Anticipated Milestones
A Look Ahead at FY 2025 Anticipated Milestones Transition to Commercialization Focus For personal use only ▪ Finalize production chemistry and atomization / post-processing parameters for C103 and Ti-64 AM Powder ▪ Commence powder sales of C103, specialty and titanium alloys; Secure multi-year comme
Slide 9: A Look Ahead at FY 2025 Anticipated Milestones (Cont.)
A Look Ahead at FY 2025 Anticipated Milestones (Cont.) For personal use only Non-Dilutive Funding ▪ Congressionally-appropriated grant funding Opportunities ▪ Industrial base acquisition and sustainment grant funding ▪ U.S. government-subsidized debt funding ▪ Commercial lending ▪ Final commissionin